Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2005; 10: 151
Spanish researchers studied the function of cannabinoid receptors in Alzheimer’s disease (AD). They found that a synthetic version of the compound prevented microglia activation in the brain, thus reducing inflammation, and acted to protect the brain. The researchers concluded that cannabinoids may succeed in preventing the neurodegenerative process occurring in AD and hope that this will eventually lead to the development of new drug therapies.
J Neurosci 2005; 25: 1904–13.
